Cetera Investment Advisers
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1666741
SCHAUMBURG, IL
Position in ALNY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$6,982,691
-$684,559 QoQ
Shares Held
23,196
+0.1% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#218
of 784 holders
Holding Since
Dec 2021
14 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cetera Investment Advisers holds $187,106,390 across 112 Biotechnology names. ALNY ranks #8 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
78,107 | $38,798,090 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
1,140,476 | $9,984,867 | |
| 3 | EXEL |
Exelixis, Inc.
|
169,657 | $9,231,037 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
14,664 | $9,143,590 | |
| 5 | OCUL |
Ocular Therapeutix, Inc
|
785,732 | $7,715,888 | |
| 6 | ARGX |
Argenx SE
|
7,844 | $7,277,427 | |
| 7 | VKTX |
Viking Therapeutics, Inc.
|
184,543 | $7,199,022 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
23,196 | $6,982,691 |
All Filings in ALNY
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,982,691 | 23,196 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $7,667,250 | 23,173 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $6,978,359 | 17,549 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,622,488 | 14,523 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,224,377 | 9,888 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,164,750 | 8,017 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $1,122,428 | 4,770 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $788,786 | 2,868 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $665,577 | 2,739 | Shares | Sole | 2024-08-22 | |
| 2024-03-31 | $531,743 | 3,558 | Shares | Sole | 2024-05-24 | |
| 2023-12-31 | $223,949 | 1,170 | Shares | Sole | 2024-02-13 | |
| 2023-03-31 | $237,779 | 1,187 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $276,386 | 1,163 | Shares | Sole | 2023-02-14 | |
| 2021-12-31 | $206,378 | 1,217 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||